Cigarette Smoking Clinical Trial
Official title:
A Virtual Arm to Stop Smoking. A Comparative Study
The investigators reported in a pilot study presented at last year's Cybertherapy Conference
(Girard & Turcotte, 2007) that using an action-cue exposure strategy in virtual reality
(ACE-VR; crushing virtual cigarettes) might be useful in the treatment of tobacco addiction.
The investigators are pursuing research in this area with a randomized control trial based
on 90 smokers who will receive a brief psychosocial smoking cessation program (25 people are
enrolled so far and we expect to finish the study before the conference). During the first
four weeks of an eight-session psychoeducational and motivational program, all participants
will be immersed in VR. During the immersions in VR, 45 of the participants will use a
virtual arm to catch and crush virtual cigarettes. The other half of the sample will use the
virtual arm to catch virtual fruits (control condition).
The smoking frequency, and abstinence, will be assessed with a daily diary and exhaled
carbon monoxide tests (the CO2 tests will provide an objective confirmation of the
abstinence reported in the diaries). The success the program will be compared based on the
number of subjects who quitted or reduced their smoking frequency. The severity of addiction
will be assessed with two questionnaires, the Fagerstrom and the Horn tests. Craving and
withdrawal effects will be measured with the Minnesota Nicotine Withdrawal Scale (MNWS) and
the Brief Questionnaire of Smoking Urges (QSU-Brief) at the baseline and at the visits from
weeks 1 through 4, 6, 12 and at the end of the program. Before the VR immersion, the
Immersive Tendencies Questionnaire will be administered and after each VR session
participants will fill two questionnaires addressing presence and cybersickness. The
comparative impact of both treatments will be tested with repeated measures ANOVAs (and
planned contrasts) with sufficient power to detect medium effect sizes.
The main goal of our study is show that crushing virtual cigarettes can boost the impact of
a behavioural program dedicated to cigarette addiction.
Status | Completed |
Enrollment | 91 |
Est. completion date | June 2009 |
Est. primary completion date | June 2008 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - adult smoker - aged 18 - 65 - willing to stop smoking - at least 10 cigarettes per day in the last year Exclusion Criteria: - receiving concomitant treatment for smoking (e.g., patches or varenicline) - weight problems : Body Mass Index < 15 kg or > 45.5 kg - suffering from a mental disorder, such as major depression, schizophrenia, etc. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Canada | GRAP - Clinique de psychologie au travail | Jonquière | Quebec |
Lead Sponsor | Collaborator |
---|---|
Universite du Quebec en Outaouais |
Canada,
Girard, B., & Turcotte, V. (2007). A virtual arm to stop smoking, a perceptual learning experiment. In N. Appel & H. Hoffman (Chairs), Addictions. Symposium presented at the Cybertherapy 12 Conference, in June in Washington, D.C.
Martin RA, Rohsenow DJ, MacKinnon SV, Abrams DB, Monti PM. Correlates of motivation to quit smoking among alcohol dependent patients in residential treatment. Drug Alcohol Depend. 2006 Jun 9;83(1):73-8. Epub 2005 Nov 28. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Self-report Measure of Abstinence in the Last 7 Days, Averaged Over Four Weeks, and Confirmed by Urine Samples. | Participants completed a daily diary to record the number cigarettes smoked during the day. No cigarette smoked during 7 days = abstinence. To be counted as real abstinence, the participant had to smoke zero cigarettes during four weeks and confirmed by zero nicoting in the unrine sample. Six measurement times were used to assess if zero cigarettes has been smoked in the last 4 weeks prior to the study (Week 1), during the first four weeks (Week 4 measurement point) and so on for a blok of four weeks ending at each measurement point (e.g., four weeks before the 12-month follow-up). |
Weeks 1, 4, 6, 12, 24 and 12-month follow-up | No |
Secondary | Tiffany's Urge to Smoke Questionnaire | Weeks 1, 4, 6, 12, 24 and 12-month follow-up | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04043728 -
Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study
|
N/A | |
Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
Active, not recruiting |
NCT02643914 -
Control Systems Approach to Predicting Individualized Dynamics of Nicotine Cravings
|
N/A | |
Recruiting |
NCT02422914 -
Benefits of Tobacco Free Cigarette
|
N/A | |
Active, not recruiting |
NCT02629679 -
Sports, Education and Consumption of Substances in Adolescents
|
N/A | |
Completed |
NCT02385227 -
Characterization of Biomarkers of Tobacco Exposure, Urge-to-Smoke Following Exclusive and Dual Ad Lib Use of Electronic Cigarettes
|
N/A | |
Completed |
NCT02218281 -
Developing a Smartphone App With Mindfulness Training for Teen Smoking Cessation
|
N/A | |
Completed |
NCT01199380 -
Behavioral Activation Intervention for Smoking Cessation in Smokers With Depressive Symptoms
|
Phase 2 | |
Completed |
NCT00802919 -
Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors
|
Phase 4 | |
Completed |
NCT01081119 -
Brief Voluntary Alcohol and Drug Intervention for Middle School Youth
|
Phase 2 | |
Completed |
NCT01692353 -
Cardiovascular Disease Biomarkers in Smokers and Moist Snuff Consumers
|
N/A | |
Completed |
NCT00756704 -
The Effectiveness of Smoking Cessation Guidelines in the Emergency Department
|
N/A | |
Completed |
NCT00682474 -
School Nurse-Delivered Smoking Cessation Intervention
|
Phase 2/Phase 3 | |
Completed |
NCT05520775 -
Semaglutide for Alcohol Use Disorder
|
Phase 2 | |
Completed |
NCT03743532 -
E-Cigarettes and Financial Incentives to Promote Tobacco Harm Reduction Among Adults Accessing Shelter Services
|
N/A | |
Terminated |
NCT03840694 -
Nicotine Withdrawal and Reward Processing: Connecting Neurobiology to Real-world Behavior
|
N/A | |
Completed |
NCT06032793 -
Effects of Deep Breathing Exercise on Pulmonary Function, Perceived Stress and Physical Fitness.
|
N/A | |
Terminated |
NCT03326128 -
High Dose Bupropion for Smoking Cessation - Pilot Study
|
Phase 2 | |
Recruiting |
NCT03218670 -
Your Health in On Click
|
N/A | |
Completed |
NCT02538042 -
Strengthening Instrumental Extinction to Prevent Smoking Relapse (VLNCCue)
|
N/A |